MX377688B - Métodos para administrar óxido nítrico a la sangre arterial o arterializada. - Google Patents

Métodos para administrar óxido nítrico a la sangre arterial o arterializada.

Info

Publication number
MX377688B
MX377688B MX2019003444A MX2019003444A MX377688B MX 377688 B MX377688 B MX 377688B MX 2019003444 A MX2019003444 A MX 2019003444A MX 2019003444 A MX2019003444 A MX 2019003444A MX 377688 B MX377688 B MX 377688B
Authority
MX
Mexico
Prior art keywords
nitric oxide
methods
arterial
arterialized blood
administering nitric
Prior art date
Application number
MX2019003444A
Other languages
English (en)
Inventor
Brahm Goldstein
Jim Potenziano
Original Assignee
Mallinckrodt Hospital Products Ip Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Hospital Products Ip Ltd filed Critical Mallinckrodt Hospital Products Ip Ltd
Publication of MX377688B publication Critical patent/MX377688B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1698—Blood oxygenators with or without heat-exchangers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621—Extra-corporeal blood circuits
    • A61M1/3666—Cardiac or cardiopulmonary bypass, e.g. heart-lung machines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0266—Nitrogen (N)
    • A61M2202/0275—Nitric oxide [NO]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invencion proporciona metodos de administracion de oxido nitrico (NO) a un paciente, el metodo que comprende el suministrar el gas que contiene oxido nitrico directamente en la sangre arterial o arterializada. Los metodos de la presente invencion se pueden utilizar en el tratamiento o prevencion de una variedad de enfermedades y trastornos sensibles al oxido nitrico, que incluye aquellos resultantes de isquemia o hipoxia.
MX2019003444A 2012-05-31 2013-05-30 Métodos para administrar óxido nítrico a la sangre arterial o arterializada. MX377688B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261653499P 2012-05-31 2012-05-31
US201361787865P 2013-03-15 2013-03-15
PCT/US2013/043232 WO2013181322A1 (en) 2012-05-31 2013-05-30 Methods of administering nitric oxide to arterial or arterialized blood

Publications (1)

Publication Number Publication Date
MX377688B true MX377688B (es) 2025-03-10

Family

ID=48626635

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2019003444A MX377688B (es) 2012-05-31 2013-05-30 Métodos para administrar óxido nítrico a la sangre arterial o arterializada.
MX2014014502A MX363507B (es) 2012-05-31 2013-05-30 Metodos para administrar óxido nítrico a la sangre arterial o arterializada.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2014014502A MX363507B (es) 2012-05-31 2013-05-30 Metodos para administrar óxido nítrico a la sangre arterial o arterializada.

Country Status (7)

Country Link
US (2) US10052426B2 (es)
EP (1) EP2854894A1 (es)
JP (2) JP6215314B2 (es)
AU (2) AU2013267418B2 (es)
CA (1) CA2874842C (es)
MX (2) MX377688B (es)
WO (1) WO2013181322A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013267418B2 (en) * 2012-05-31 2018-06-07 Mallinckrodt Hospital Products IP Limited Methods of administering nitric oxide to arterial or arterialized blood
US9629358B2 (en) * 2013-03-15 2017-04-25 Mallinckrodt Hospital Products IP Limited Administration and monitoring of nitric oxide in ex vivo fluids
ES2981406T3 (es) 2013-03-15 2024-10-08 Mallinckrodt Pharmaceuticals Ireland Ltd Administración y monitorización de óxido nítrico en fluidos ex vivo
BR112019004635A2 (pt) * 2016-09-10 2019-06-18 Vero Biotech LLC sistema e método para liberação de óxido nítrico portátil
US12397090B2 (en) 2017-06-08 2025-08-26 Case Western Reserve University Devices and methods for nitrosylation of blood
JP2020532531A (ja) * 2017-08-30 2020-11-12 ベレロフォン パルス テクノロジーズ エルエルシー 肺疾患に関連付けられる肺高血圧症の治療のための吸入用一酸化窒素の使用
CN113797404B (zh) * 2021-01-06 2023-05-09 郝云玲 一种向血液中补充一氧化氮（no）的装置
WO2023086409A1 (en) * 2021-11-12 2023-05-19 The Feinstein Institutes For Medical Research Methods and medical compositions administered to protect mammals treated using an extracorporeal membrane oxygenation device
CN120456938A (zh) 2022-12-16 2025-08-08 费森尤斯医疗保健控股公司 用于在透析中使用一氧化氮的系统和方法
WO2025047854A1 (ja) * 2023-08-31 2025-03-06 公立大学法人奈良県立医科大学 ヘモグロビン含有溶液の溶存気体交換方法および装置

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5725492A (en) 1996-03-04 1998-03-10 Cormedics Corp Extracorporeal circulation apparatus and method
JP4258908B2 (ja) * 1999-09-14 2009-04-30 株式会社ジェイ・エム・エス 人工肺装置
US20080160107A1 (en) 2002-09-10 2008-07-03 Nitric Biotherapeutics, Inc. Use of nitric oxide gas to treat blood and blood products
US7485324B2 (en) * 2003-09-29 2009-02-03 Pulmonox Technologies Corporation Use of exogenous gaseous nitric oxide in the treatment and disinfection of biofilms
JP4562490B2 (ja) * 2004-10-26 2010-10-13 泉工医科工業株式会社 人工肺ガス交換モニタ
US8790715B2 (en) * 2006-02-16 2014-07-29 Ino Therapeutics Llc Method and apparatus for generating nitric oxide for medical use
AU2013267418B2 (en) * 2012-05-31 2018-06-07 Mallinckrodt Hospital Products IP Limited Methods of administering nitric oxide to arterial or arterialized blood

Also Published As

Publication number Publication date
AU2018203332B2 (en) 2019-09-19
WO2013181322A1 (en) 2013-12-05
MX363507B (es) 2019-03-26
JP2015519143A (ja) 2015-07-09
CA2874842C (en) 2021-01-26
JP2018011979A (ja) 2018-01-25
JP6215314B2 (ja) 2017-10-18
AU2013267418A1 (en) 2014-12-04
AU2013267418B2 (en) 2018-06-07
AU2018203332A1 (en) 2018-05-31
US20150151034A1 (en) 2015-06-04
US10052426B2 (en) 2018-08-21
EP2854894A1 (en) 2015-04-08
MX2014014502A (es) 2015-05-11
US20180339095A1 (en) 2018-11-29
CA2874842A1 (en) 2013-12-05

Similar Documents

Publication Publication Date Title
MX377688B (es) Métodos para administrar óxido nítrico a la sangre arterial o arterializada.
DOP2014000170A (es) Compuestos de imidazopirrolidinona
PH12015502042A1 (en) Use of linagliptin in cardio-and renoprotective antidiabetic therapy
PH12014501997A1 (en) Esketamine for the treatment of treatment-refractory or treatment-resistant depression
BR112015022197A2 (pt) tratamento de cataplexia
JOP20130236B1 (ar) تركيبات صيدلانية تشتمل على مثبط b-raf ومثبط egfr ومثبط اختياري لــpi3k alpha
PH12015500407A1 (en) Methods of treating hypertriglyceridemia
MX380273B (es) Conjugados de farmacos anticuerpo (adcs) con inhibidores de ksp.
IN2014MN02089A (es)
UA117451C2 (uk) Терапевтично активні сполуки і способи їх застосування
BR112015012014A2 (pt) proteínas de ligação específicas duais penetrando a barreira hematoencefálica (bbb)
MX353964B (es) Agentes terapeuticos y usos de los mismos.
UA116999C2 (uk) Виділене антитіло до гемаглютиніну та фармацевтична композиція, що його містить
EA201490254A1 (ru) Комбинированное лечение гепатита с
MX373851B (es) Métodos de administración de tratamiento con pirfenidona.
EA201591679A1 (ru) Способ нетоксического лечения абстиненции, вызванной лекарственным средством
PE20160012A1 (es) Tratamiento de enfermedades miopaticas y neurogenerativas por agregacion de proteina mediante administracion parenteral
WO2013155528A3 (en) Methods for reducing brain inflammation, increasing insulin sensitivity, and reducing ceramide levels
HK1201155A1 (en) Basal insulin therapy
WO2012138911A3 (en) Conjugates of anti-hiv drugs and somatostatin analogs
EA201500765A1 (ru) Способы лечения сердечно-сосудистых заболеваний
BR112015011849A2 (pt) método de preparação de formas de cristal de 4 (ciclopropilmetoxi)-n-(3,5-dicloro-1-oxidopiridin-4-il)-5-metoxipiridina-2-carboxamida e formas de cristal da mesma
BR112014033118A2 (pt) combinações farmacêuticas de um inibidor de cdk4/6 e um inibidor de b-raf
PL414926A1 (pl) Zastosowanie medyczne N-podstawionych pochodnych 3-amino-4-fenylo-5-oksopirazolinokarboksamidu do wytwarzania leku
BR112013025934A2 (pt) tratamento de infecção pelo vírus da hepatite c com alisporivir